![Prognostic factors of long‑term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12‑year experience from a single center Prognostic factors of long‑term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12‑year experience from a single center](https://www.spandidos-publications.com/article_images/ol/13/3/ol-13-03-1157-g03.jpg)
Prognostic factors of long‑term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12‑year experience from a single center
![Time-trend and recurrence analysis of pancreatic neuroendocrine tumors in: Endocrine Connections Volume 8 Issue 7 (2019) Time-trend and recurrence analysis of pancreatic neuroendocrine tumors in: Endocrine Connections Volume 8 Issue 7 (2019)](https://ec.bioscientifica.com/view/journals/ec/8/7/images/EC-19-0282fig4.jpeg)
Time-trend and recurrence analysis of pancreatic neuroendocrine tumors in: Endocrine Connections Volume 8 Issue 7 (2019)
![Cancers | Free Full-Text | Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States Cancers | Free Full-Text | Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States](https://www.mdpi.com/cancers/cancers-15-00840/article_deploy/html/images/cancers-15-00840-g005.png)
Cancers | Free Full-Text | Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States
![Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study - ScienceDirect Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1365182X17309395-gr2.jpg)
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study - ScienceDirect
![Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67 | Annals of Surgical Oncology Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67 | Annals of Surgical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1245%2Fs10434-018-6518-2/MediaObjects/10434_2018_6518_Fig1_HTML.gif)
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67 | Annals of Surgical Oncology
![Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study - The Lancet Regional Health – Europe Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/935f1b96-9506-4283-93aa-861c2d0bf8e2/gr1.jpg)
Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study - The Lancet Regional Health – Europe
![Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines in: Endocrine-Related Cancer Volume 24 Issue 2 (2017) Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines in: Endocrine-Related Cancer Volume 24 Issue 2 (2017)](https://erc.bioscientifica.com/view/journals/erc/24/2/images/large/71fig1.jpeg)
Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines in: Endocrine-Related Cancer Volume 24 Issue 2 (2017)
![PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dbefbcff3d1adac4d9382c85f93ecfd16024f5f9/3-Figure1-1.png)
PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar
![Survival outcomes in patients with pancreatic neuroendocrine tumor. a... | Download Scientific Diagram Survival outcomes in patients with pancreatic neuroendocrine tumor. a... | Download Scientific Diagram](https://www.researchgate.net/publication/311566788/figure/fig1/AS:960056577228804@1605906733690/Survival-outcomes-in-patients-with-pancreatic-neuroendocrine-tumor-a-Progression-free.gif)
Survival outcomes in patients with pancreatic neuroendocrine tumor. a... | Download Scientific Diagram
![Frontiers | Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis Frontiers | Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis](https://www.frontiersin.org/files/Articles/1140873/fendo-14-1140873-HTML/image_m/fendo-14-1140873-g001.jpg)
Frontiers | Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
![Cancers | Free Full-Text | Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know Cancers | Free Full-Text | Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know](https://www.mdpi.com/cancers/cancers-13-05969/article_deploy/html/images/cancers-13-05969-g001.png)
Cancers | Free Full-Text | Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know
![Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study | Journal of Clinical Oncology Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2016.34.issue-32/jco.2016.34.issue-32/20161102/jco.2016.34.issue-32.largecover.jpg)
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study | Journal of Clinical Oncology
![Survival curves in different surgical status subgroup patients with... | Download Scientific Diagram Survival curves in different surgical status subgroup patients with... | Download Scientific Diagram](https://www.researchgate.net/publication/320226891/figure/fig2/AS:670325251514397@1536829402697/Survival-curves-in-different-surgical-status-subgroup-patients-with-pancreatic.png)
Survival curves in different surgical status subgroup patients with... | Download Scientific Diagram
![An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan | Scientific Reports An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-86839-2/MediaObjects/41598_2021_86839_Fig1_HTML.png)
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan | Scientific Reports
![Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma | AJR Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma | AJR](https://ajronline.org/cms/10.2214/AJR.19.21921/asset/images/large/08_19_21921_06.jpeg)
Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma | AJR
![Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike? - ScienceDirect Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842821002808-ga1.jpg)
Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike? - ScienceDirect
![C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms | Scientific Reports C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-03187-x/MediaObjects/41598_2021_3187_Fig1_HTML.png)